This systematic review and network meta-analysis found that spinal cord stimulation therapies for treatment of chronic pain in back and/or lower extremities were associated with greater improvements ...
Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.
A nurse from Kent has told how being fitted with spinal cord stimulation for chronic pain has allowed her to keep doing her ...
Chris Patterson retired before Christmas 2022, after falling and breaking his back. He has faced several issues trying to get ...
GlobalData on MSN3d
Nevro secures CE mark for AI-based spinal cord stimulation systemUS-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...
WATE Knoxville on MSN3d
‘I’m in pain every day’ Retired Knoxville firefighter seeks workers’ comp solution after career-ending injuryKNOXVILLE, Tenn. (WATE) — Chris Patterson was a Knoxville fire captain when he rescued a woman from a house fire in December ...
A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...
Data from the SENZA-PDN trial showed 10 kHz SCS yielded long-term, clinically meaningful reductions in HbA1c and weight in patients with PDN and T2D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback